Manipal Health Enterprises IPO Review
Manipal Health Enterprises IPO is yet to receive analyst coverage — analyst reports and verdicts will be updated here as and when they are published. The IPO is priced in the band of ₹560-590 per share with a minimum lot size of 25 shares (minimum investment of ₹14,750) . Subscription opens on 29 Jul 2026 and closes on 31 Jul 2026. In the meantime, you can track the live GMP and subscription status for early market signals.
Table of Contents
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Manipal Health Enterprises IPO?
Analyst coverage for Manipal Health Enterprises IPO has not been published yet. Analyst verdicts will be updated here as they come in — check back closer to the subscription dates.
What does the score of N/A mean for Manipal Health Enterprises IPO?
Analyst scoring is not yet available for Manipal Health Enterprises IPO. The score will be updated once analyst reports start coming in.
What are the listing gain expectations for Manipal Health Enterprises IPO?
The grey market premium (GMP) for Manipal Health Enterprises IPO is currently ₹50 (8.5%), which suggests the street is pricing a listing above the issue price. Keep in mind that GMP is an unofficial, unregulated indicator and can shift sharply in the 24–48 hours before listing. Track the live GMP page for real-time updates.
What is the price band and lot size of Manipal Health Enterprises IPO?
Manipal Health Enterprises IPO is priced at ₹560-590 per share. The minimum lot size is 25 shares, making the minimum investment approximately ₹14,750 at the upper end of the price band. The subscription window is open from 29 Jul 2026 to 31 Jul 2026.
Explore Manipal Health Enterprises IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!